ImmunityBio, Inc.IBRXNASDAQ
Loading
Research and development spending
3Y CAGR
-4.7%/yr
vs +46.8%/yr prior
5Y CAGR
+9.0%/yr
Recent deceleration
Acceleration
-51.5pp
Decelerating
Percentile
P83
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $215.01M | +13.1% |
| 2024 | $190.14M | -18.2% |
| 2023 | $232.37M | -6.4% |
| 2022 | $248.15M | +26.6% |
| 2021 | $195.96M | +40.5% |
| 2020 | $139.51M | +185.4% |
| 2019 | $48.88M | -8.5% |
| 2018 | $53.42M | +34.3% |
| 2017 | $39.78M | +49.8% |
| 2016 | $26.55M | - |